The increased expression of MMP-9 through the NF-κB-dependent pathway has been implicated in the acceleration of gastric inflammation and the pathogenesis of GC, a condition characterized by poor survival [27,28,29]. The gene discussed is MMP9; the disease is gastric cancer.